retatrutide clinical trials safety efficacy Lilly's triple agonist achieves 16.8% weight loss in phase 3 trial Retatrutide, an investigational triple hormone
Pay in 4 interest-free payments of $5.59 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

00967-0/asset/e600c3fc-c7b2-4bc5-adb8-0138decc3ad3/main.assets/gr3_lrg.jpg)


























